132 related articles for article (PubMed ID: 36921171)
1. Clinical and laboratory differences between pediatric hospitalized patients with sickle cell disease infected or not by SARS-CoV-2.
Elia GM; Konstantyner T; Nais RP; Santos ARAD; Angel A; Braga JAP
Rev Paul Pediatr; 2023; 41():e2021407. PubMed ID: 36921171
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Hospitalized Children Positive for SARS-CoV-2: Experience of a Large Center.
Webb NE; Osburn TS
Hosp Pediatr; 2021 Aug; 11(8):e133-e141. PubMed ID: 34011567
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
Balanchivadze N; Kudirka AA; Askar S; Almadhoun K; Kuriakose P; Fadel R; Dabak V
Hemoglobin; 2020 Jul; 44(4):284-289. PubMed ID: 32722950
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID-19: A 2.5-year follow-up study.
Feit A; Gordon M; Alamuri TT; Hou W; Mitchell WB; Manwani D; Duong TQ
Eur J Haematol; 2023 Oct; 111(4):636-643. PubMed ID: 37492929
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and follow-up of pediatric patients hospitalized for COVID-19.
Tang F; Luo W; Wang X; Li H; Mei H; Shao J; Song Q
Pediatr Pulmonol; 2021 Jul; 56(7):1967-1975. PubMed ID: 33852775
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
Aggarwal A; Shrivastava A; Kumar A; Ali A
J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
[TBL] [Abstract][Full Text] [Related]
11. Is cardiorespiratory disease associated with increased susceptibility of SARS-CoV-2 in children?
Du Berry C; Saunders T; McMinn A; Tosif S; Shanthikumar S; Vandeleur M; Harrison J; Burgner D; Ranganathan S; Crawford N; Wurzel D
Pediatr Pulmonol; 2021 Dec; 56(12):3664-3668. PubMed ID: 34473903
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation of pediatric patients with symptomatic SARS-CoV-2 infection during the first months of the COVID-19 pandemic in a single center in Mexico City.
Aragón-Nogales R; Zurita-Cruz J; Vázquez-Rosales G; Arias-Flores R; Gómez-González C; Montaño-Luna V; Sámano-Aviña M; Pacheco-Rosas D; Flores-Ruiz E; Villasís-Keever M; Miranda-Novales G
Front Pediatr; 2022; 10():912784. PubMed ID: 35967584
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.
Hoogenboom WS; Alamuri TT; McMahon DM; Balanchivadze N; Dabak V; Mitchell WB; Morrone KB; Manwani D; Duong TQ
Blood Rev; 2022 May; 53():100911. PubMed ID: 34838342
[TBL] [Abstract][Full Text] [Related]
15. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China.
Wang L; Li X; Chen H; Yan S; Li D; Li Y; Gong Z
Am J Nephrol; 2020; 51(5):343-348. PubMed ID: 32229732
[TBL] [Abstract][Full Text] [Related]
17. Relevant SARS-CoV-2 viremia is associated with COVID-19 severity: Prospective cohort study and validation cohort.
Cardeñoso Domingo L; Roy Vallejo E; Zurita Cruz ND; Chicot Llano M; Ávalos Pérez-Urria E; Barrios A; Hernando Santos J; Ortiz J; Rodríguez García SC; Martín Ramírez A; Ciudad Sañudo M; Marcos C; García Castillo E; Fontán García-Rodrigo L; González B; Méndez R; Iturrate I; Sanz García A; Villa A; Sánchez Azofra A; Quicios B; Arribas D; Álvarez Rodríguez J; Patiño P; Trigueros M; Uriarte M; Triguero Martínez A; Arévalo C; Galván Román JM; García-Vicuña R; Ancochea J; Soriano JB; Canabal A; Muñoz Calleja C; De la Cámara R; Suarez Fernández C; González Álvaro I; Rodríguez-Serrano DA;
J Med Virol; 2022 Nov; 94(11):5260-5270. PubMed ID: 35811284
[TBL] [Abstract][Full Text] [Related]
18. Emergency department visits and hospitalizations for pediatric vaso-occlusive pain events during the COVID-19 pandemic.
Romanos-Sirakis E; Demissie S
Pediatr Blood Cancer; 2023 Apr; 70(4):e30213. PubMed ID: 36633226
[TBL] [Abstract][Full Text] [Related]
19. Parental Coronavirus Disease 2019 Testing of Hospitalized Children: Rethinking Infection Control in a Pandemic.
Hassoun A; Prasad N; Pugh S; Merced I; Abularrage J; Sharma M
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):564-565. PubMed ID: 32856705
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
Du H; Dong X; Zhang JJ; Cao YY; Akdis M; Huang PQ; Chen HW; Li Y; Liu GH; Akdis CA; Lu XX; Gao YD
Allergy; 2021 Feb; 76(2):510-532. PubMed ID: 32524611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
